https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
47 per 0.1 increase [95%CI 0.28 to 0.77]; p=0.003) and residual reference plaque burden (hazard ratio 4.01 per 10% increase [95%CI 1.50 to 10.77]; p=0.006) were identified as independent predictors of DOCE by Cox multivariable analysis. Nonuniform device expansion and substantial untreated residual plaque in reference segments were associated with long-term adverse events following BVS implantation. Baseline imaging to identify the appropriate device landing zone and procedural imaging to achieve uniform device expansion if
Like
Comment
Share
